Joint Formulary & PAD

Rifaximin 550mg tablets - Hepatic encephalopathy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
Restricted use on recommendation of Gastroenterology consultants for treatment of hepatic encephalopathy.

PAD Profile

ChemicalSubstance :
Rifaximin 550mg tablets
Indication :
Hepatic encephalopathy
Group Name :
Keywords :
NICE, AMBER, Shared Care, antibiotic, antibacterial
Brand Names Include :
Targaxan
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Rifaximin 550mg tablets is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hepatic encephalopathy.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed that rifaximin for the reduction in  recurrence of episodes of overt hepatic encephalopathy in patients ≥ 18 years of age, has a BLUE (with flow chart/pathway) traffic light status. See below for agreed documentation